who owns the patent for semaglutide Last week's expiry of semaglutide—the active ingredient in Novo Nordisk's blockbuster drugs that are used to treat both diabetes and obesity—unleashed a flurry of launches of low-cost generic versions Why Delhi HC rejected semaglutide

GHK-Cu (50mg vial + 2ml BAC water): 25 mg/ml concentration

Because research is ongoing, it is essential to follow medical advice and report any unusual symptoms promptly

[PubMed]^8 These statements have not been evaluated by the FDA for the treatment or prevention of any specific disease

"I think it's disappointing to think that a registered pharmacist would see that it was an ethical thing to do and it's not in keeping with their pharmacy registration." The Sydney pharmacist running TCP, Emad Azzer, has now had his registration suspended completely

Many patients begin GLP-1 therapy expecting rapid weight loss at the starting dose of 0.5mg semaglutide, but the reality is more nuanced

For the full picture on muscle loss and body composition during GLP-1 therapy, see our guide on GLP-1s and muscle loss